<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>13646807</identifier>
<setSpec>0370-9590</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>SOTO, R J</dc:author>
<dc:author>ROZADOS, I B</dc:author>
<dc:author>FLASTER, H</dc:author>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>OBESITY/therapy</dc:subject>
<dc:subject>SYMPATHOMIMETICS/therapeutic use</dc:subject>
<dc:date>1958 Oct 30 </dc:date>
<dc:title xml:lang="es">Resultados obtenidos con el uso del clorhidrato de 2 fenil-3 metil tetrahido 1, 4-oxazina como coadyuvante en el tratamiento de la obesidad.</dc:title>
<dc:title xml:lang="en">[Results obtained using 2-phenyl-3-methyl-1, 4-tetrahydro-oxazine as adjuvant in the therapy of obesity].</dc:title>
<dc:publisher>La Semana medica</dc:publisher>
</metadata>
</record>
</pubmed-document>
